LIVE: From Specimen to Result: Streamlining Breast Cancer Biomarker Workflows in a Hybrid Academic-Community Health System
LIVE WEBINAR: AUGUST 6, 2026 | 1:00-2:00pm ET
Registration includes the live webinar link (sent via Zoom), the webinar recording, and PDF of the slides.
Description
In this webinar we will explore the implementation of precision cancer biomarker testing pathways in a hybrid health system comprised of both private-community and academic practice settings. We will broadly cover the technology and administrative processes used to create these testing pathways, with a deeper focus specifically on the breast cancer disease state.
Learning Objectives
- Examine implementation of a flexible NGS-oncology testing solution enabling disease-specific and comprehensive cancer diagnostics.
- Identify key steps in the development of multi-disciplinary cancer biomarker testing pathways.
- Evaluate the impact of in-system biomarker testing on quality of cancer patient care.
Speaker
Andrew C. Nelson, MD, PhD
University of Minnesota
Moderator
Antonia R. Sepulveda, MD, PhD
The George Washington University School of Medicine and Health Sciences
Level of Instruction: Intermediate
Live Webinar: August 6, 2026 | 1:00pm ET
Certificate: Learners will be awarded a Certificate of Attendance at the conclusion of the course. CME or CMLE credits are NOT available for this educational series.
This educational series is supported by funding from Amgen and AstraZeneca
This is the second of four webinars in a series. Click here for more information on the series: Streamlining Oncology Precision Testing Protocols: Present Practices, Prospects and Problems
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.